Fresenius Medical Care AG & Co. KGaA announced a change in the Management Board. After being with the company for more than 20 years Roberto Fust, the Management Board member responsible for the region Asia-Pacific, has decided to resign from his operational responsibilities and Management Board position effective March 31, 2016.

The company will continue to benefit from Mr. Fuste's experience as he will continue to support the CEO Rice Powell as an Executive Advisor for regional strategy up until 2018. Effective April 1, 2016 Mr. Harry de Wit will succeed Mr. Fust as the CEO and Management Board member for the region and he will also be located in Hong Kong. Mr. de Wit has worked in various areas in the medical device industry for over 25 years.

Since 2010 Mr. de Wit served as President Asia at Covidien (now Medtronic) in Singapore.